caffeic acid phenethyl ester has been researched along with tetrahydrocurcumin in 1 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (tetrahydrocurcumin) | Trials (tetrahydrocurcumin) | Recent Studies (post-2010) (tetrahydrocurcumin) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 170 | 4 | 112 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | tetrahydrocurcumin (IC50) |
|---|---|---|---|
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 3.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SJ; Lee, ES; Nam, JH; Shin, DH; Zhang, Y | 1 |
1 other study(ies) available for caffeic acid phenethyl ester and tetrahydrocurcumin
| Article | Year |
|---|---|
Inhibition of Ca(2+) release-activated Ca(2+) channel (CRAC) by curcumin and caffeic acid phenethyl ester (CAPE) via electrophilic addition to a cysteine residue of Orai1.
Topics: Caffeic Acids; Calcium; Calcium Channels; Curcumin; Cysteine; HEK293 Cells; Humans; Mutation; ORAI1 Protein; Phenylethyl Alcohol | 2012 |